Ubi Pharma Inc is a Taiwan-based company mainly engaged in development and manufacturing of protein drugs and special dosage-form drugs. The Company is engaged in research and development, manufacturing and sales of protein drugs and special dosage-form drugs, contract manufacturing of pharmaceuticals, and provision of contract research services.

Employees

Sector

Pharmaceuticals

More about the company

End-of-day quote Taipei Exchange 06/05/2024			5-day change	1st Jan Change
14.25 ^TWD	+1.79%		-.--%	-

13/08	UBI Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
27/04	UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Market Cap	1.68B 52.84M 46.95M 43.82M 39.94M 75.32M 5.08B 76.03M 530M 205M 2.6B 198M 194M 8.33B	P/E 2024	-9.63x	P/E 2025	-5.68x
Enterprise Value	1.97B 61.91M 55.01M 51.34M 46.79M 88.25M 5.95B 89.07M 621M 241M 3.04B 232M 227M 9.76B	EV / Sales 2024	3.58x	EV / Sales 2025	3.83x
Free-Float	27.79%	Yield 2024 *	-	Yield 2025	-

13/08	UBI Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2026	CI
27/04	UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
12/08/25	UBI Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
30/04/25	UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
13/08/24	UBI Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2024	CI
18/04/24	UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
11/08/23	UBI Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	CI
21/04/23	UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
15/08/22	UBI Pharma Inc. Reports Earnings Results for the Half Year Ended June 30, 2022	CI
29/04/22	UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	CI
29/04/22	UBI Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	CI
16/08/21	Medigen Vaccine Biologics : Taiwan rejects COVID vaccine candidate, president to get domestic shot	RE
16/08/21	Medigen Vaccine Biologics : Taiwan denies approval for UBI's COVID-19 vaccine candidate	RE

3 years	10	38.5
5 years	10	96.24
10 years	8.34	288.72

UBI Pharma Inc. Stock

Stocks

6562

TW0006562002

Pharmaceuticals

Valuation: UBI Pharma Inc.

Latest news: UBI Pharma Inc.

Quotes and Performance

Price Extremes

Managers and Directors: UBI Pharma Inc.

Other Pharmaceuticals

Financials

Company Profile

Manager	Title	Age	Since
Jung Kuang Yang CEO	Chief Executive Officer	-	-
Meng Han Hsu DFI	Director of Finance/CFO	-	11/04/2016
Ying Yun Fan ADM	Chief Administrative Officer	-	01/03/2015

Director	Title	Age	Since
Ying Yun Fan BRD	Director/Board Member	-	30/06/2020
Yan Ning Kuo BRD	Director/Board Member	-	30/06/2020
Yao Hui Wei BRD	Director/Board Member	-	30/06/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
UBI PHARMA INC.	+1.79%	-.--%	-.--%	-58.15%	52.84M
ELI LILLY AND COMPANY	-0.61%	-3.43%	+36.07%	+117.61%	1,019B
JOHNSON & JOHNSON	-1.02%	-5.60%	+35.72%	+64.82%	617B
ABBVIE INC.	+1.11%	-0.58%	+12.36%	+78.27%	464B
MERCK & CO., INC.	+0.34%	-3.01%	+61.79%	+41.79%	356B
ROCHE HOLDING AG	-0.95%	-4.05%	+20.54%	+40.33%	333B
NOVARTIS AG	-1.46%	-2.89%	+10.57%	+26.54%	267B
ASTRAZENECA PLC	-1.35%	-5.43%	-6.17%	+8.82%	244B
AMGEN INC.	-1.04%	-2.79%	+35.30%	+54.42%	218B
GILEAD SCIENCES, INC.	-1.87%	-4.10%	+28.44%	+97.54%	179B
Average	-0.51%	-2.61%	+23.46%	+47.20%	369.72B
Weighted average by Cap.	-0.60%	-3.33%	+29.07%	+71.15%

	2024	2025
Net sales	539M 16.92M 15.03M 14.03M 12.79M 24.11M 1.63B 24.34M 170M 65.78M 831M 63.51M 62.13M 2.67B	514M 16.15M 14.35M 13.39M 12.21M 23.02M 1.55B 23.24M 162M 62.8M 794M 60.63M 59.32M 2.55B
Net income	-175M -5.48M -4.87M -4.54M -4.14M -7.81M -527M -7.88M -54.98M -21.3M -269M -20.57M -20.12M -864M	-296M -9.3M -8.26M -7.71M -7.03M -13.26M -894M -13.38M -93.34M -36.17M -457M -34.92M -34.16M -1.47B
Net Debt	246M 7.73M 6.87M 6.41M 5.85M 11.02M 743M 11.13M 77.61M 30.07M 380M 29.04M 28.41M 1.22B	289M 9.07M 8.06M 7.52M 6.85M 12.93M 872M 13.05M 91.01M 35.27M 446M 34.05M 33.31M 1.43B